在II型粘多糖糖症患者的酶替代疗法中,长期心血管结果和死亡率
Ji Hee Kwak1, Yong Jun Choi2, Sinae Kim3
1Department of Pediatrics, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Journal of inherited metabolic disease
|July 30, 2024
概括
酶替代疗法 (ERT) 显著降低了主要心脏不良事件 (MACE) 和II型粘多糖症 (MPS II) 的死亡率. 早期启动ERT改善了结果,突出了对MPS II患者及时治疗和综合护理的需要.
科学领域:
- 罕见的遗传疾病 罕见的遗传疾病
- lysosomal 储存疾病 lysosomal 储存疾病
- 心血管医学 心血管医学
背景情况:
- 粘多糖症II型 (MPS II) 是一种罕见的多系统性溶酶体疾病.
- 心脏功能障碍和心力衰竭是MPS II的重要并发症.
- 关于MPS II.中主要不良心脏事件 (MACE) 结果的数据有限.
研究的目的:
- 评估韩国MPS II患者的心血管结果.
- 评估酶替代疗法 (ERT) 对MACE和死亡率的影响.
- 在MPS II中识别MACE的风险因素.
主要方法:
- 使用国家医疗保险数据库进行的国家队列研究.
- 在14年的时间里,包括127名MPS II患者.
- 从诊断开始追踪MACE发生率;用于调整危险比率的Cox建模.
主要成果:
- 在平均7.3年的随访期间发现了16例MACE病例 (17.35/1000人年).
- 与未接受治疗的患者相比,ERT显著降低了MACE的发生率.
- 早期启动ERT与改善结果和增加存活率有关.
结论:
- 早期ERT显著降低了MACE风险,并改善了MPS II中的存活率.
- 及时启动治疗和全面护理对于管理MPS II至关重要.
- 需要扩展治疗策略来提高MPS II的整体结果.
相关概念视频
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...